Strategic Wealth Advisors Group, LLC Ionis Pharmaceuticals Inc Transaction History
Strategic Wealth Advisors Group, LLC
- $2.33 Billion
- Q3 2022
A detailed history of Strategic Wealth Advisors Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Strategic Wealth Advisors Group, LLC holds 12,729 shares of IONS stock, worth $464,990. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,729
Previous 12,090
5.29%
Holding current value
$464,990
Previous $445,000
26.52%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$518 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$377 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$319 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$288 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.19B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...